Open AccessVariants of Transient Receptor Potential Melastatin Member 4 in Childhood Atrioventricular Block
Author(s) -
Syam Ninda,
Chatel Stéphanie,
Ozhathil Lijo Cherian,
Sottas Valentin,
Rougier JeanSébastien,
Baruteau Alban,
Baron Estelle,
Amarouch MohamedYassine,
Daumy Xavier,
Probst Vincent,
Schott JeanJacques,
Abriel Hugues
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.114.001625
Subject(s) - brugada syndrome , atrioventricular block , medicine , loss function , transient receptor potential channel , microbiology and biotechnology , mutation , genetics , gene , receptor , endocrinology , phenotype , biology
Background Transient receptor potential melastatin member 4 ( TRPM 4) is a nonselective cation channel. TRPM 4 mutations have been linked to cardiac conduction disease and Brugada syndrome. The mechanisms underlying TRPM 4‐dependent conduction slowing are not fully understood. The aim of this study was to characterize TRPM 4 genetic variants found in patients with congenital or childhood atrioventricular block. Methods and Results Ninety‐one patients with congenital or childhood atrioventricular block were screened for candidate genes. Five rare TRPM 4 genetic variants were identified and investigated. The variants were expressed heterologously in HEK 293 cells. Two of the variants, A432T and A432T/G582S, showed decreased expression of the protein at the cell membrane; inversely, the G582S variant showed increased expression. Further functional characterization of these variants using whole‐cell patch‐clamp configuration showed a loss of function and a gain of function, respectively. We hypothesized that the observed decrease in expression was caused by a folding and trafficking defect. This was supported by the observation that incubation of these variants at lower temperature partially rescued their expression and function. Previous studies have suggested that altered SUMO ylation of TRPM 4 may cause a gain of function; however, we did not find any evidence that supports SUMO ylation as being directly involved for the gain‐of‐function variant. Conclusions This study underpins the role of TRPM 4 in the cardiac conduction system. The loss‐of‐function variants A432T/G582S found in 2 unrelated patients with atrioventricular block are most likely caused by misfolding‐dependent altered trafficking. The ability to rescue this variant with lower temperature may provide a novel use of pharmacological chaperones in treatment strategies.